[Cetiprin 'Kabi' (emepronium bromide). A new anticholinergic agent with selective action on the urinary bladder].
D001555:Benzene Derivatives / Q000494:pharmacology; D006801:Humans; D009103:Multiple Sclerosis / Q000503:physiopathology; D009135:Muscular Diseases / Q000503:physiopathology; D010276:Parasympatholytics / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D001743:Urinary Bladder / Q000187:drug effects* / Q000503:physiopathology
D001555:Benzene Derivatives; D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds
Cetiprin "Kabi" (emepronium bromid). Et nytt antikolinergikum med selektiv virkning på urinblaeren